insights_auto
Why is EDIT down 2,41%?
Dive Deeperchevron_right
EDIT:NASDAQ
Editas Medicine Inc
1,82 $
arrow_downward
-2,41%(-0,045) 1D
1,92 $
arrow_upward
+5,21% (+0,095)bedtimeAfter hours
Closed: 17 նոյ, 16:00:01 GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for EDIT...
Open
1,90 $
High
1,94 $
Low
1,82 $
Mkt. cap
281,67 մլն
Avg. vol.
2,41 մլն
Volume
0,00
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
Open
1,90 $
High
1,94 $
Low
1,82 $
Mkt. cap
281,67 մլն
Avg. vol.
2,41 մլն
Volume
0,00
52-wk high
3,94 $
52-wk low
1,66 $
EPS
-0,62 $
Beta
2,09
Shares outstanding
154,34 մլն
No. of employees
87
News stories
From web sources and news partners
Trefis
·
1 ժամ առաջ
9 S&P 500 Stocks Just Made New 52-Week Lows
Benzinga
·
1 ժամ առաջ
Stock Market: Will S&P 500 Open Up or Down Today?
Latest news from Azerbaijan
·
53 րոպե առաջ
Dow, S&P 500, Nasdaq futures extend losses for fourth session amid AI sell-off
Traders Union
·
6 ժամ առաջ
S&P 500 rises 10 percent amid challenging backdrop, Nate Geraci notes
Profile
Editas Medicine, Inc., is a clinical-stage biotechnology company that is developing therapies for rare diseases using CRISPR gene editing technology. Editas Medicine headquarters is located in Cambridge, Massachusetts with additional facilities in Boulder, Colorado. Wikipedia
About Editas Medicine Inc